2023-10-05 16:15:32
Cancer: New Drug Shows Promise in Killing Metastases
A groundbreaking new drug has been developed by researchers that could potentially halt tumor growth. The medication utilizes nanoparticles, which specifically target the tissue affected by a cancerous tumor. Unlike healthy tissue, the diseased tissue is characterized by holes, providing ample opportunities for the particles to attack.
The nanoparticles employed in this drug are coated with a light-sensitive substance. When exposed to light, they absorb the energy and become activated. In this state, the nanoparticles initiate chemical reactions that effectively destroy the tumor cells. By inducing oxidative stress in the cancer cells, the activated nanoparticles disrupt their metabolic processes and lead to damage. This oxidative stress also activates the immune system, prompting immune cells to identify and fight the impaired cancer cells.
However, it should be noted that the nanoparticles not only attack the cancer cells within the tumor but also target any cells in the body that resemble the damaged cancer cells, including metastases that have spread as the disease progresses.
Further research is required to fully establish the effectiveness of this drug, and these investigations are expected to take several years. This groundbreaking research is being conducted at the Washington University’s Center for Multiple Myeloma Nanotherapy in the United States, where three pilot projects utilizing nanoparticles are currently underway.
Exciting Findings: A recent study reveals an increased risk of cancer associated with dietary supplements. For more details, click here.
The German Cancer Research Center projects approximately 510,000 new cancer cases for 2022 in Germany alone, averaging around 1,400 new cases per day. The most prevalent types of cancer in the country are breast cancer (25%), colon cancer (20%), prostate cancer (20%), and lung cancer (12%).
Fortunately, cancer mortality rates in Germany have significantly declined in recent years. In 2020, approximately 230,000 individuals succumbed to the disease, resulting in a death rate of 110 per 100,000 inhabitants.
Nanotechnology as a Beacon of Hope in Cancer Treatment
Nanotechnology is set to play a pivotal role in the future of cancer treatment. Promising drugs like the one discussed here may be available for use within a few years. The federal government also recognizes the vast potential of nanotechnology and envisions a future where nano-based “drug ferries” are utilized. These nanoparticles, armed with specific active ingredients targeting individual tumors, could be programmed to differentiate between healthy and diseased tissue. They would then attach themselves to the tumor cells and release the active ingredients in a precise and targeted manner, potentially offering an alternative to conventional chemotherapy treatments.
]
#Nanoparticles #kill #tumors #milestone #cancer #research